BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17643544)

  • 1. Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles.
    Gratton SE; Pohlhaus PD; Lee J; Guo J; Cho MJ; Desimone JM
    J Control Release; 2007 Aug; 121(1-2):10-8. PubMed ID: 17643544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials.
    Rolland JP; Maynor BW; Euliss LE; Exner AE; Denison GM; DeSimone JM
    J Am Chem Soc; 2005 Jul; 127(28):10096-100. PubMed ID: 16011375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micromolding for the fabrication of biological microarrays.
    Galloway AL; Murphy A; Rolland JP; Herlihy KP; Petros RA; Napier ME; DeSimone JM
    Methods Mol Biol; 2011; 671():249-60. PubMed ID: 20967635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pursuit of a scalable nanofabrication platform for use in material and life science applications.
    Gratton SE; Williams SS; Napier ME; Pohlhaus PD; Zhou Z; Wiles KB; Maynor BW; Shen C; Olafsen T; Samulski ET; Desimone JM
    Acc Chem Res; 2008 Dec; 41(12):1685-95. PubMed ID: 18720952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aspect ratio and deformability on nanoparticle extravasation through nanopores.
    Kersey FR; Merkel TJ; Perry JL; Napier ME; DeSimone JM
    Langmuir; 2012 Jun; 28(23):8773-81. PubMed ID: 22612428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-circulating Janus nanoparticles made by electrohydrodynamic co-jetting for systemic drug delivery applications.
    Rahmani S; Villa CH; Dishman AF; Grabowski ME; Pan DC; Durmaz H; Misra AC; Colón-Meléndez L; Solomon MJ; Muzykantov VR; Lahann J
    J Drug Target; 2015; 23(7-8):750-8. PubMed ID: 26453170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRINT: a novel platform toward shape and size specific nanoparticle theranostics.
    Perry JL; Herlihy KP; Napier ME; Desimone JM
    Acc Chem Res; 2011 Oct; 44(10):990-8. PubMed ID: 21809808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles.
    Glangchai LC; Caldorera-Moore M; Shi L; Roy K
    J Control Release; 2008 Feb; 125(3):263-72. PubMed ID: 18053607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward therapeutic delivery with layer-by-layer engineered particles.
    Yan Y; Such GK; Johnston AP; Lomas H; Caruso F
    ACS Nano; 2011 Jun; 5(6):4252-7. PubMed ID: 21612259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles.
    Merkel TJ; Chen K; Jones SW; Pandya AA; Tian S; Napier ME; Zamboni WE; DeSimone JM
    J Control Release; 2012 Aug; 162(1):37-44. PubMed ID: 22705460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomolding of PEG-based hydrogels with sub-10-nm resolution.
    Diez M; Mela P; Seshan V; Möller M; Lensen MC
    Small; 2009 Dec; 5(23):2756-60. PubMed ID: 19787679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin particle formation in supersaturated aqueous solutions of poly(ethylene glycol).
    Bromberg L; Rashba-Step J; Scott T
    Biophys J; 2005 Nov; 89(5):3424-33. PubMed ID: 16254391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-pot aqueous phase growth of biocompatible 15-130 nm gold nanoparticles stabilized with bidentate PEG.
    Oh E; Susumu K; Jain V; Kim M; Huston A
    J Colloid Interface Sci; 2012 Jun; 376(1):107-11. PubMed ID: 22480398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Room-temperature preparation and characterization of poly (ethylene glycol)-coated silica nanoparticles for biomedical applications.
    Xu H; Yan F; Monson EE; Kopelman R
    J Biomed Mater Res A; 2003 Sep; 66(4):870-9. PubMed ID: 12926040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenging nature's monopoly on the creation of well-defined nanoparticles.
    Jeong W; Napier ME; DeSimone JM
    Nanomedicine (Lond); 2010 Jun; 5(4):633-9. PubMed ID: 20528457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shape-specific, monodisperse nano-molding of protein particles.
    Kelly JY; DeSimone JM
    J Am Chem Soc; 2008 Apr; 130(16):5438-9. PubMed ID: 18376832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a library of particles having controlled sizes and shapes via the mechanical elongation of master templates.
    Wang Y; Merkel TJ; Chen K; Fromen CA; Betts DE; DeSimone JM
    Langmuir; 2011 Jan; 27(2):524-8. PubMed ID: 21166444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles.
    Roberts RA; Shen T; Allen IC; Hasan W; DeSimone JM; Ting JP
    PLoS One; 2013; 8(4):e62115. PubMed ID: 23593509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
    Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
    J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.